Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of STN deep brain stimulation and levodopa on pain threshold in idiopathic Parkinson's disease
2010-019354-40Phase 4Completed
- Sponsor
- Medical University of Innsbruck, University Clinic for Neurology
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of levodopa in Parkinson's disease (PD), sponsored by Medical University of Innsbruck, University Clinic for Neurology. Primary endpoint: Primary: Change in pain threshold with STN-DBS ON/OFF vs OFF/OFF. Started Apr 2010; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2010-019354-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019354-40.